Elligo CEO John Potthoff discusses how COVID-19 has impacted clinical trial participation and execution and why diversity in clinical trials is critical at the J.P. Morgan Healthcare Conference.



When you need direct access to physicians and their known patients or research practice management solutions to accelerate your clinical trials, there’s Only Elligo.

Contact Us